Essex Investment Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
1,136,630
+235,232
+26% +$933K 0.67% 55
2026
Q1
$3.33M Buy
+901,398
New +$3.37M 0.53% 71
2023
Q4
– Sell
-372,106
Closed -$1.19M – 321
2023
Q3
$1.19M Buy
+372,106
New +$1.73M 0.19% 162
2019
Q2
– Sell
-256,755
Closed -$1.62M – 476
2019
Q1
$1.62M Sell
256,755
-8,595
-3% -$66.5K 0.24% 137
2018
Q4
$1.72M Sell
265,350
-17,647
-6% -$107K 0.27% 120
2018
Q3
$2.01M Buy
282,997
+11,630
+4% +$64.6K 0.24% 134
2018
Q2
$1.18M Buy
+271,367
New +$1M 0.15% 204

Other funds holding APYX

Essex Investment Management's APYX Position: Q2 2026 in Review

Essex Investment Management increased its Apyx Medical (APYX) stake by 26% in Q2 2026, buying an estimated $933K and bringing the position to 1,136,630 shares worth $5.1M. The position accounts for 0.67% of the portfolio, ranked #55.

Essex Investment Management first reported a position in APYX in Q2 2018 and has held it in 7 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Essex Investment Management held 1,136,630 shares of Apyx Medical worth $5.1M as of Q2 2026.
  • Essex Investment Management bought 235,232 Apyx Medical shares in Q2 2026, an estimated $933K.
  • Apyx Medical made up 0.67% of Essex Investment Management's portfolio in Q2 2026, its #55 holding.
  • Essex Investment Management first reported a position in Apyx Medical in Q2 2018 and has held it in 7 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Essex Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.